
Jnana Therapeutics
AcquiredJnana Therapeutics is a biotech company in Boston, United States, founded in 2017. It has raised $207.0M across 3 rounds, most recently a $107.0M Series C in November 2022.
Enlightened innovation. Expansive therapeutic impact.
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- jnanatx.com
- Total Funding
- $207.0M
- Last Round
- $107.0M Series CNov 2022
- Rounds
- 3
- Acquisition Date
- Aug 2024
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 7 investors for this company. The full record is or through the API.
About
Jnana Therapeutics is a clinical-stage biotechnology company founded in 2017 and headquartered in Boston, Massachusetts, that leverages its proprietary RAPID chemoproteomics platform to discover small molecule medicines for rare genetic metabolic and immune-mediated diseases. The RAPID platform enables systematic identification of unique binding sites on highly validated but historically hard-to-drug protein targets, dramatically accelerating the path from target to clinical candidate. Jnana's lead program, JNT-517, is an oral allosteric inhibitor targeting phenylketonuria (PKU), a serious inherited metabolic disorder; in 2024 the company was acquired by Otsuka Pharmaceutical for approximately $800 million, becoming a subsidiary of Otsuka America.
Summary
It lists 51–200 employees. It has raised $207.0M in total across 3 rounds, most recently a $107.0M Series C round in Nov 2022. Investors include RA Capital Management, Polaris Partners and Bain Capital Life Sciences.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Aug 2024
Sign up to see all 4 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/jnana-therapeutics"><img src="https://indexed.vc/api/badge/company/jnana-therapeutics" alt="Jnana Therapeutics on Indexed.vc" width="260" height="76" /></a>
